Why COVID-19 Testing Is a Tragic Waste STORY

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
200
Why COVID-19 Testing Is a Tragic Waste

STORY AT-A-GLANCE

PCR tests are not designed to be used as a diagnostic tool as they cannot distinguish between inactive viruses and “live” or reproductive ones

Amplification over 35 cycles is considered unreliable and scientifically unjustified, yet many labs use 45 cycles. This amplifies any tiny sequence of viral DNA that might be present to the point that the test reads “positive” even if the viral load is extremely low or the virus is inactive

The PCR test can also pick up the presence of other coronaviruses, so a positive result may simply indicate that you’ve recuperated from a common cold in the past

Millions of people are simply carrying inactive viral DNA that pose no risk to anyone, yet positive test results are being used by the global technocracy to implement a brand new economic and social system based on draconian surveillance and totalitarian controls

Research shows the global lockdown strategy harms public health to a greater degree than the virus itself


https://articles.mercola.com/sites/articles/a...1010377629
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sales Focus Inc. Awarded as Leading Medical Outsourcing Service

Updated Category News Views 112

Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...

Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry

Updated Category News Views 76

Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....

Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential

Updated Category News Views 177

Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...

Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled

Updated Category News Views 168

BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...

Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact

Updated Category News Views 171

Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...

Continue Reading